RESUMO
The use of oral fluid (OF) as an alternative specimen for drug analysis has become very popular in forensic toxicology. Many clinical studies have evaluated the correlations between concentrations of cocaine and its metabolites in OF and other matrices, but results have shown high variability. In addition, there are no data available regarding the correlations between biomarkers of crack-cocaine use in different matrices. This study evaluated the relationship between concentrations of cocaine/crack-cocaine biomarkers in OF, urine and plasma samples collected from cocaine users. All samples were analyzed for the presence of cocaine (COC), benzoylecgonine (BZE) and anhydroecgonine (AEC) by a validated liquid chromatography-mass spectrometry method. Median COC, BZE and AEC concentrations ranged from 4.20 to 33.26 ng/mL, from 13.03 to 3,615.86 ng/mL and from 7.40 to 1,892.5 ng/mL across matrices, respectively. The relationship between drug concentrations in OF versus plasma (OF/P) and OF versus urine (OF/U) was evaluated by their coefficients of determination (R2). Least-squares regression analyses demonstrated significant correlations between OF/P and OF/U for cocaine and BE (P < 0.05), with R2 = 0.17, 0.07 for cocaine and R2 = 0.73, 0.45 for BE, respectively. The correlation coefficients (r) found for BZE, COC and AEC in OF/P and OF/U were 0.85 and 0.67 (P < 0.05); 0.41 and 0.26 (P < 0.05); and 0.30 and -0.37 (P > 0.05), respectively. Many factors contribute to the variability of drug correlation ratios in studies involving random samples, including uncertainty about the time of last administration and dosage. Overall, we found significant R2 values for COC and BZE in OF/P and OF/U, but not for AEC. Despite the good correlations found in some cases, especially for BZE, the large variation in drug concentrations seen in this work suggests that OF concentrations should not be used to estimate concentrations of COC, BZE or AEC in plasma and/or urine.
Assuntos
Transtornos Relacionados ao Uso de Cocaína , Cocaína/análise , Toxicologia Forense/métodos , Saliva/química , Detecção do Abuso de Substâncias/métodos , Adulto , Biomarcadores/sangue , Biomarcadores/urina , Brasil , Cromatografia Líquida , Cocaína/sangue , Cocaína/urina , Transtornos Relacionados ao Uso de Cocaína/sangue , Transtornos Relacionados ao Uso de Cocaína/urina , Cocaína Crack/análise , Cocaína Crack/sangue , Cocaína Crack/urina , Estudos Transversais , Feminino , Humanos , Masculino , Espectrometria de MassasRESUMO
The use of point-of-collection testing (POCT) devices for drugs of abuse in oral fluid (OF) is an advantageous tool that has been used for different purposes-particularly traffic enforcement. However, even with the widespread report of cocaine consumption, the reliability of POCT devices has been reported in different magnitudes. This study evaluated the reliability of two POCT devices for the detection of cocaine in OF samples of 110 cocaine users: (i) the DDS2™ (cutoff = 30 ng/mL) and (ii) the Multi-Drugs Multi-Line-Twist Screen Test Device™ (MDML) (cutoff = 20 ng/mL). Results of the screening tests were compared with a Liquid Chromatography-Mass Spectrometry (LC-MS) assay. Sensitivity, specificity and accuracy of DDS2™ were 100, 77.77 and 80% when compared with LC-MS with a cutoff of 30 ng/mL, and 88.89, 89.15 and 89.09% with a cutoff of 10 ng/mL. The MDML™ device achieved sensitivity, specificity and accuracy of 100, 65.6 and 70.9% when compared with LC-MS with a cutoff of 20 ng/mL, and 92.6, 71.1 and 76.6% with a cutoff of 10 ng/mL. When compared with a 10 ng/mL cutoff, the DDS2™ achieved reliability parameters higher than 80%. On the other hand, the MDML™ device did not achieve the minimal recommendation of 80% for all parameters at the same time. Taking into consideration the reliability results showed here, the authors believe that the use of these POCT devices seems to be suitable for cocaine detection in forensic tests only if all positive specimens are further confirmed by a validated method.
Assuntos
Cocaína/análise , Entorpecentes/análise , Saliva/química , Detecção do Abuso de Substâncias/métodos , Cromatografia Gasosa-Espectrometria de Massas , Reprodutibilidade dos TestesRESUMO
BACKGROUND: Substance use disorders are associated with the increased risk of driving under the influence (DUI), but little is known about crack-cocaine and its relationship with road traffic crashes (RTC). METHOD: A multicenter sample of 765 crack-cocaine users was recruited in six Brazilian capitals in order to estimate the prevalence of DUI and RTC involvement. Legal, psychiatric, and drug-use aspects related with traffic safety were evaluated using the Addiction Severity Index - 6th version (ASI-6) and the Mini International Neuropsychiatric Interview. RESULTS: Seventy-six (28.3%) current drivers reported accident involvement following crack-cocaine use. Among drivers (n=269), 45.7% and 30.5% reported DUIs in the past 6 months and 30 days, respectively. Drivers reporting DUI's in the past month (n=82) had higher scores in the "psychiatric", "legal", and "family problems" subscales from the ASI-6, and lower scores in the "family social support" subscale in comparison to those without a history of DUIs (n=187). An overall high prevalence of psychiatric comorbidity and substance consumption was observed. Participants with 5+ years of crack-cocaine use were more likely to have been in a RTC (RR=1.52, 95%IC: 1.02-2.75), independently of marijuana use, binge drinking and psychiatric comorbidities. CONCLUSION: The high prevalence of RTC and DUI involvement among crack-using drivers supports the idea that they are at a high risk group regarding traffic safety. Years of crack consumption seem to be associated with RTC involvement. Also, the presence of psychiatric comorbidities, poly-drug use, and cognitive impairment usually associated with crack addiction could yield additional risk of accidents.
Assuntos
Acidentes de Trânsito/estatística & dados numéricos , Condução de Veículo/psicologia , Transtornos Relacionados ao Uso de Cocaína/psicologia , Cocaína Crack , Dirigir sob a Influência/estatística & dados numéricos , Acidentes de Trânsito/psicologia , Adulto , Brasil/epidemiologia , Estudos Transversais , Dirigir sob a Influência/psicologia , Feminino , Humanos , Masculino , PrevalênciaRESUMO
This study analyzes the available evidence on the adequacy of economic evaluation for decision-making on the incorporation or exclusion of technologies for rare diseases. The authors conducted a structured literature review in MEDLINE via PubMed, CRD, LILACS, SciELO, and Google Scholar (gray literature). Economic evaluation studies had their origins in Welfare Economics, in which individuals maximize their utilities based on allocative efficiency. There is no widely accepted criterion in the literature to weigh the expected utilities, in the sense of assigning more weight to individuals with greater health needs. Thus, economic evaluation studies do not usually weigh utilities asymmetrically (that is, everyone is treated equally, which in Brazil is also a Constitutional principle). Healthcare systems have ratified the use of economic evaluation as the main tool to assist decision-making. However, this approach does not rule out the use of other methodologies to complement cost-effectiveness studies, such as Person Trade-Off and Rule of Rescue.
Assuntos
Análise Custo-Benefício/economia , Doenças Raras/economia , Avaliação da Tecnologia Biomédica/economia , Tomada de Decisões , Atenção à Saúde/economia , Ética em Pesquisa , Humanos , Política Pública/economiaRESUMO
This study analyzes the available evidence on the adequacy of economic evaluation for decision-making on the incorporation or exclusion of technologies for rare diseases. The authors conducted a structured literature review in MEDLINE via PubMed, CRD, LILACS, SciELO, and Google Scholar (gray literature). Economic evaluation studies had their origins in Welfare Economics, in which individuals maximize their utilities based on allocative efficiency. There is no widely accepted criterion in the literature to weigh the expected utilities, in the sense of assigning more weight to individuals with greater health needs. Thus, economic evaluation studies do not usually weigh utilities asymmetrically (that is, everyone is treated equally, which in Brazil is also a Constitutional principle). Healthcare systems have ratified the use of economic evaluation as the main tool to assist decision-making. However, this approach does not rule out the use of other methodologies to complement cost-effectiveness studies, such as Person Trade-Off and Rule of Rescue.
El objetivo fue sistematizar las evidencias disponibles sobre la pertinencia de utilizar la evaluación económica para la incorporación/exclusión de tecnología en enfermedades raras. Se realizó una revisión sistemática de la literatura en MEDLINE vía PubMed, CRD, LILACS, SciELO y Google Académico (literatura gris). Los estudios de evaluación económica se originan de la Economía del Bienestar, en la que los individuos maximizan sus utilidades, basándose en la eficiencia de asignación. No existe un criterio ampliamente aceptado para examinar las utilidades, a fin de dar más peso a los individuos con mayores necesidades. Generalmente, los estudios no equilibran asimétricamente las utilidades, todas son consideradas iguales, lo que en Brasil es también un principio constitucional. Los sistemas de salud han ratificado el uso de la evaluación económica como la principal herramienta para ayudar en la toma de decisiones. Sin embargo, este abordaje no excluye el uso de otras metodologías complementarias a los estudios de coste-efectividad, como la técnica de compensación personal o la regla del rescate.
O objetivo deste estudo foi analisar as evidências disponíveis sobre a adequação do uso de avaliação econômica sobre incorporação/exclusão de tecnologias para doenças raras. Foi realizada uma revisão estruturada da literatura, nas bases MEDLINE, via PubMed, CRD, LILACS, SciELO e Google Acadêmico (literatura cinzenta). Os estudos de avaliação econômica têm origem na Economia do Bem-Estar, na qual os indivíduos maximizam suas utilidades, fundamentando-se na eficiência alocativa. Não há um critério amplamente aceito para ponderar as utilidades esperadas, no sentido de dar mais peso aos indivíduos com maiores necessidades em saúde. Geralmente não se ponderam assimetricamente as utilidades; todas são tratadas de forma igualitária, que, no caso brasileiro, também é um princípio constitucional. Os sistemas de saúde têm ratificado o uso de avaliação econômica como principal instrumento para auxiliar na tomada de decisão. No entanto, essa postura não exclui o uso de outras metodologias complementares aos estudos de custo-efetividade, como Person Trade-Off e regra de resgate.
Assuntos
Animais , Humanos , Camundongos , Aterosclerose/enzimologia , Aterosclerose/patologia , Células Espumosas/enzimologia , Metaloproteinases da Matriz/metabolismo , Ruptura Aórtica/etiologia , Ruptura Aórtica/prevenção & controle , Aterosclerose/complicações , Aterosclerose/imunologia , Células Espumosas/patologia , Regulação Enzimológica da Expressão Gênica , Metabolismo dos Lipídeos , Modelos Imunológicos , Metaloproteinases da Matriz/genética , Infarto do Miocárdio/complicações , Infarto do Miocárdio/enzimologia , Infarto do Miocárdio/imunologia , Infarto do Miocárdio/patologia , Miócitos de Músculo Liso/patologia , Inibidores Teciduais de Metaloproteinases/imunologia , Inibidores Teciduais de Metaloproteinases/metabolismoRESUMO
OBJECTIVE: According to the World Health Organization, the global burden of road traffic mortality exceeds 1.27 million people annually; over 90 percent occur in low- and middle-income countries. Brazil's road traffic mortality rate of â¼20 per 100,000 is significantly higher than nearby Chile or Argentina. To date, there has been very little information published on road traffic fatalities among vulnerable road users (VRUs) in Brazil. METHODS: Road traffic fatality data from 2000 to 2008 were extracted from Brazil's Mortality Information System (SIM). Road traffic deaths were extracted using the International Classification of Diseases (ICD-10) V-codes (V01-V89) and then subcategorized by VRU categories. Information was then disaggregated by gender, age, and region. RESULTS: In 2008, 39,211 deaths due to road traffic injuries were recorded in Brazil, resulting in a crude mortality rate of 20.7 per 100,000 inhabitants. Pedestrian mortality averaged 5.46 deaths per 100,000 between 2000 and 2008. The mortality rate for elderly pedestrians (80+ years) is 20.1 per 100,000, over 10 times that of 0- to 9-year-olds. In the past decade, motorcycle occupant mortality has dramatically increased by over 300 percent from 1.5 per 100,000 in 2000 to 4.7 per 100,000 in 2008. The 20- to 29-year age group remains most affected by motorcycle deaths, with a peak fatality rate of 10.76 per 100,000 in 2008. The north and northeast regions, with the lower per capita gross domestic product (GDP), have higher proportions of VRU deaths compared with other regions. CONCLUSIONS: Vulnerable road users are contributing an increasing proportion of the road traffic fatalities in Brazil. Nationally, elderly pedestrians are at particularly high risk and motorcycle fatalities are increasing at a rapid rate. Less prosperous regions have higher proportions of VRU deaths. Understanding the epidemiology of road traffic mortality in vulnerable road user categories will better allow for targeted interventions to reduce these preventable deaths.
Assuntos
Acidentes de Trânsito/mortalidade , Ciclismo/estatística & dados numéricos , Motocicletas/estatística & dados numéricos , Acidentes de Trânsito/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Brasil/epidemiologia , Criança , Pré-Escolar , Bases de Dados Factuais , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Distribuição por Sexo , Adulto JovemRESUMO
Objetivo: Analisar a relação entre condições macroeconômicas e saúde no Brasil. Métodos: Para analisar o impacto do emprego e a renda sobre a mortalidade, utilizou-se um painel de dados para o Brasil em nível estadual para o período de 1981-2002. Como proxy para saúde, foram utilizadas as informações sobre a taxa de mortalidade obtidas do Sistema de Informações sobre Mortalidade (SIM). Para as condições macroeconômicas, foram empregadas as variáveis emprego e renda média e para os aspectos socioeconômicos, considerou-se a taxa de analfabetismo. Os efeitos das variáveis foram estimados por modelos estático e dinâmico a fim de analisar duas hipóteses: 1) a hipótese de Ruhm, que sugere que elevadas taxas de emprego e de renda estão associadas com maior taxa de mortalidade e 2) a hipótese de Brenner, que indica que elevadas taxas de emprego e de renda estão relacionadas a menores taxas de mortalidade. Resultados: A relação entre a taxa de mortalidade (proxy utilizada para a saúde) com as condições macroeconômicas (mensurada por meio da taxa de emprego) se mostrou negativa. As estimativas indicaram que a taxa de mortalidade total foi maior nos períodos de recessão econômica, sugerindo que à medida que as condições macroeconômicas melhoram, aumentando o nível de emprego na economia, ocorreu uma queda na taxa de mortalidade...
Assuntos
Emprego , Escolaridade , Indicadores Econômicos , Mortalidade , Renda , Fatores SocioeconômicosRESUMO
OBJECTIVE: To analyze the relationship between macroeconomic conditions and health in Brazil. METHODS: The analysis of the impact of employment and income on mortality in Brazil was based on panel data from Brazilian states between 1981 and 2002. Mortality rates obtained from the national mortality database was used as a proxy for health status, whereas the variables employment, income, and illiteracy rates were used as proxies for macroeconomic and socioeconomic conditions. Static and dynamic models were applied for the analysis of two hypotheses: a) there is a positive relationship between mortality rates and income and employment, as suggested by Ruhm; b) there is a negative relationship between mortality rates and income and employment, as suggested by Brenner. RESULTS: There was found a negative relationship between mortality rates (proxy for health) and macroeconomic conditions (measured by employment rate). The estimates indicated that the overall mortality rate was higher during economic recession, suggesting that as macroeconomic conditions improved, increasing employment rates, there was a decrease in the mortality rate. The estimate for the relationship between illiteracy (proxy for education level) and mortality rate showed that higher levels of education can improve health. CONCLUSIONS: The results from the static and dynamic models support Brenner's hypothesis that there is a negative relationship between mortality rates and macroeconomic conditions.
Assuntos
Emprego/estatística & dados numéricos , Nível de Saúde , Renda/estatística & dados numéricos , Mortalidade , Brasil/epidemiologia , Recessão Econômica/estatística & dados numéricos , Escolaridade , Humanos , Modelos EconômicosRESUMO
OBJETIVO: Analisar fatores determinantes do status de saúde em cada estado da Região Nordeste do Brasil. MÉTODOS: Estudo utilizando a metodologia de dados em painel, com informações agregadas para municípios. Os dados compreendem os anos de 1991 e 2000, e foram obtidos no Atlas do Desenvolvimento Humano do Programa das Nações Unidas para o Desenvolvimento, e Secretaria do Tesouro Nacional. Utilizou-se como indicador do status de saúde, a taxa de mortalidade infantil, e como determinantes as variáveis: gastos com saúde e saneamento per capita, números de médicos por mil habitantes, acesso à água tratada, taxa de fecundidade e de analfabetismo, percentual de mães adolescentes, renda per capita e índice de Gini. RESULTADOS: As taxas de mortalidade infantil na região Nordeste reduziram-se em 31,8 por cento no período analisado, desempenho pouco superior ao apresentado para a média nacional. No entanto, em alguns estados, como Rio Grande do Norte, Bahia, Ceará e Alagoas, a redução foi mais significativa. Isso pode ser atribuído à melhora de alguns indicadores que são os principais determinantes da redução da taxa de mortalidade infantil: maior acesso à educação, redução da taxa de fecundidade, aumento da renda, e do acesso à água. CONCLUSÕES: Os estados que apresentaram maiores ganhos no acesso à água tratada, educação, renda e redução da taxa de fecundidade, foram também os que obtiveram maiores ganhos na redução da mortalidade de menores de um ano de idade.
OBJECTIVE: To assess health status determinants in Brazil's Northeast states. METHODS: Study carried out based on panel data analysis of aggregated information for municipalities. Data was obtained from the United Nations Development Program Atlas of Human Development and Brazilian National Treasury Department for the years 1991 and 2000. Health status indicator was infant mortality rate and health determinants were the following variables: per capita health and sanitation expenditure; number of physicians per inhabitant; access to drinking water; fertility rate; illiteracy rate; percentage of adolescent mothers; per capita income; and Gini coefficient. RESULTS: Infant mortality rates in Northeast Brazil were reduced by 31.8 percent, during the period studied, slightly above the national average. However, in some states, such as Rio Grande do Norte, Bahia, Ceará and Alagoas, the reduction was more significant. This can be attributed to improvement in some indicators that are main determinants of infant mortality rate reduction: greater access to education, reduction of fertility rates, increased income, and access to drinking water. CONCLUSIONS: Brazilian states that showed greater gains in access to drinking water, education, income and reduction of fertility rates were also the ones that achieved major reductions in mortality of children under a year of age.
OBJETIVO: Analizar factores determinantes del estatus de salud en cada estado de la región del Noreste de Brasil. MÉTODOS: Se realizó estudio utilizando la metodología de datos de panel, con informaciones agregadas para municipios. Los datos comprenden los años de 1991 y 2000, y fueron obtenidos en el Atlas de Desarrollo Humano del Programa de las Naciones Unidas para el Desarrollo, y Secretaria del Tesoro Nacional. Se utilizó como indicador del estatus de salud, la tasa de mortalidad infantil, y como determinantes las variables: gastos con salud y saneamiento per capita, números de médicos por mil habitantes, acceso a agua tratada, tasa de fecundidad y de analfabetismo, porcentaje de madres adolescentes, renta per capita e índice de Gini. RESULTADOS: Las tasas de mortalidad infantil en la región del Noreste se redujeron en 31 por ciento en el período analizado, desempeño poco superior al presentando para el promedio nacional. Sin embargo, en algunos estados, como Río Grande del Norte, Bahía, Ceará y Alagoas, la reducción fue más significativa. Esto puede ser atribuido a la mejoría de algunos indicadores que son los principales determinantes de la reducción de la tasa de mortalidad infantil: mayor acceso a la educación, reducción de la tasa de fecundidad, aumento de la renta, y del acceso al agua. CONCLUSIONES: Los estados que presentaron mayores beneficios en el acceso al agua tratada, educación, renta y reducción de la tasa de fecundidad, fueron los que obtuvieron mayores beneficios en la reducción de la mortalidad de menores de un año de edad.